AZD2423 Single Ascending Dose Study in Healthy Japanese Subjects - JSAD

Study identifier:D2600C00003

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of oral AZD2423 after Single Ascending Doses in Healthy Japanese Male and Non-Fertile Female Volunteers

Medical condition

Healthy Volunteer

Phase

Phase 1

Healthy volunteers

Yes

Study drug

AZD2423, Placebo

Sex

All

Actual Enrollment

32

Study type

Interventional

Age

20 Years - 55 Years

Date

Study Start Date: 01 Aug 2009
Primary Completion Date: 01 Dec 2009
Study Completion Date: 01 Dec 2009

Study design

Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Basic Science

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria